# General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation

Study · id `cardio:ct-nct02896595` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02896595](<https://clinicaltrials.gov/study/NCT02896595>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02896595

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02896595. Randomized; double masking; primary purpose health services research. Start 2016-09 (actual); primary completion 2018-12-11 (actual). Results posted on 2020-01-21.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Started: 2016-09 (actual) (ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Primary completion: 2018-12-11 (actual) (ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Completion: 2019-01-31 (actual) (ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Results first posted: 2020-01-21 (ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02896595, source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02896595-2020-01-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Device): General Anesthesia with endotracheal tube
- Intervention (Device): General Anesthesia with laryngeal mask airway
- Lead sponsor: Virginia Commonwealth University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Virginia Commonwealth University (`cardio:org-virginia-commonwealth-university`)

## Provenance

Content hash: de6bbe599ec79019c55cdce69c948a11b82b8ab2b0dddaa4447c00cbeed4564b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
